4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000670
Director sold 31,992 shares at an average $16.56 ($529,938)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-07-11 | Sale : show line 1 in the form | −14,120 | $16.52 | $233,262 | 2,426,435 | I |
| 2017-07-12 | Sale : show line 2 in the form | −17,872 | $16.60 | $296,675 | 2,408,563 | I |
| Open-market sales · 31,992 sh · avg $16.56 · $529,938 | ||||||
Loading xslF345X03/vonemster_fm4july112017.xml…